Medical Care
Global Catheter-Related Bloodstream Infections (CRBSIs) Market Research Report 2025
- May 05, 25
- ID: 226105
- Pages: 76
- Figures: 72
- Views: 41
The global market for Catheter-Related Bloodstream Infections (CRBSIs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Catheter-Related Bloodstream Infections are infections that occur as a result of the presence of a catheter (a thin tube) in a blood vessel. These infections can lead to serious medical complications and are a significant concern in healthcare settings.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Catheter-Related Bloodstream Infections (CRBSIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Catheter-Related Bloodstream Infections (CRBSIs).
The Catheter-Related Bloodstream Infections (CRBSIs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Catheter-Related Bloodstream Infections (CRBSIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Catheter-Related Bloodstream Infections (CRBSIs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals Ltd
Xellia Pharmaceuticals Ltd
Fresenius Medical Care
Merck & Co., Inc.
Geistlich Pharma AG
TauroPhar GmbH
Segment by Type
Anti-microbial Agents
Antibiotic Lock Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Catheter-Related Bloodstream Infections (CRBSIs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Catheter-Related Bloodstream Infections are infections that occur as a result of the presence of a catheter (a thin tube) in a blood vessel. These infections can lead to serious medical complications and are a significant concern in healthcare settings.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Catheter-Related Bloodstream Infections (CRBSIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Catheter-Related Bloodstream Infections (CRBSIs).
The Catheter-Related Bloodstream Infections (CRBSIs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Catheter-Related Bloodstream Infections (CRBSIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Catheter-Related Bloodstream Infections (CRBSIs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals Ltd
Xellia Pharmaceuticals Ltd
Fresenius Medical Care
Merck & Co., Inc.
Geistlich Pharma AG
TauroPhar GmbH
Segment by Type
Anti-microbial Agents
Antibiotic Lock Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Catheter-Related Bloodstream Infections (CRBSIs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-microbial Agents
1.2.3 Antibiotic Lock Therapy
1.3 Market by Application
1.3.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Perspective (2020-2031)
2.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Growth Trends by Region
2.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Region (2020-2025)
2.2.3 Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2026-2031)
2.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Dynamics
2.3.1 Catheter-Related Bloodstream Infections (CRBSIs) Industry Trends
2.3.2 Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
2.3.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
2.3.4 Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue
3.1.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue (2020-2025)
3.1.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Players (2020-2025)
3.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Catheter-Related Bloodstream Infections (CRBSIs) Revenue
3.4 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio
3.4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2024
3.5 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs) Head office and Area Served
3.6 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Product and Application
3.7 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Type
4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Type (2020-2025)
4.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2026-2031)
5 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Application
5.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Application (2020-2025)
5.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
6.2 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
6.4 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
7.2 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
7.4 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
8.2 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
9.2 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
9.4 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
10.2 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals Ltd
11.1.1 Glenmark Pharmaceuticals Ltd Company Details
11.1.2 Glenmark Pharmaceuticals Ltd Business Overview
11.1.3 Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.1.4 Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.1.5 Glenmark Pharmaceuticals Ltd Recent Development
11.2 Xellia Pharmaceuticals Ltd
11.2.1 Xellia Pharmaceuticals Ltd Company Details
11.2.2 Xellia Pharmaceuticals Ltd Business Overview
11.2.3 Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.2.4 Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.2.5 Xellia Pharmaceuticals Ltd Recent Development
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Details
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.3.4 Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.3.5 Fresenius Medical Care Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.4.4 Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Geistlich Pharma AG
11.5.1 Geistlich Pharma AG Company Details
11.5.2 Geistlich Pharma AG Business Overview
11.5.3 Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.5.4 Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.5.5 Geistlich Pharma AG Recent Development
11.6 TauroPhar GmbH
11.6.1 TauroPhar GmbH Company Details
11.6.2 TauroPhar GmbH Business Overview
11.6.3 TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.6.4 TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.6.5 TauroPhar GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-microbial Agents
1.2.3 Antibiotic Lock Therapy
1.3 Market by Application
1.3.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Perspective (2020-2031)
2.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Growth Trends by Region
2.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Region (2020-2025)
2.2.3 Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2026-2031)
2.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Dynamics
2.3.1 Catheter-Related Bloodstream Infections (CRBSIs) Industry Trends
2.3.2 Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
2.3.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
2.3.4 Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue
3.1.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue (2020-2025)
3.1.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Players (2020-2025)
3.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Catheter-Related Bloodstream Infections (CRBSIs) Revenue
3.4 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio
3.4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2024
3.5 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs) Head office and Area Served
3.6 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Product and Application
3.7 Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Type
4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Type (2020-2025)
4.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2026-2031)
5 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Application
5.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Application (2020-2025)
5.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
6.2 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
6.4 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
7.2 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
7.4 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
8.2 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
9.2 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
9.4 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2020-2031)
10.2 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals Ltd
11.1.1 Glenmark Pharmaceuticals Ltd Company Details
11.1.2 Glenmark Pharmaceuticals Ltd Business Overview
11.1.3 Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.1.4 Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.1.5 Glenmark Pharmaceuticals Ltd Recent Development
11.2 Xellia Pharmaceuticals Ltd
11.2.1 Xellia Pharmaceuticals Ltd Company Details
11.2.2 Xellia Pharmaceuticals Ltd Business Overview
11.2.3 Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.2.4 Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.2.5 Xellia Pharmaceuticals Ltd Recent Development
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Details
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.3.4 Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.3.5 Fresenius Medical Care Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.4.4 Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Geistlich Pharma AG
11.5.1 Geistlich Pharma AG Company Details
11.5.2 Geistlich Pharma AG Business Overview
11.5.3 Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.5.4 Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.5.5 Geistlich Pharma AG Recent Development
11.6 TauroPhar GmbH
11.6.1 TauroPhar GmbH Company Details
11.6.2 TauroPhar GmbH Business Overview
11.6.3 TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.6.4 TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
11.6.5 TauroPhar GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-microbial Agents
Table 3. Key Players of Antibiotic Lock Therapy
Table 4. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2020-2025)
Table 8. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2026-2031)
Table 10. Catheter-Related Bloodstream Infections (CRBSIs) Market Trends
Table 11. Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
Table 12. Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
Table 13. Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
Table 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players (2020-2025)
Table 16. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2024)
Table 17. Ranking of Global Top Catheter-Related Bloodstream Infections (CRBSIs) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Headquarters and Area Served
Table 20. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Product and Application
Table 21. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2020-2025)
Table 25. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2026-2031)
Table 27. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2020-2025)
Table 29. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2026-2031)
Table 31. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Glenmark Pharmaceuticals Ltd Company Details
Table 47. Glenmark Pharmaceuticals Ltd Business Overview
Table 48. Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 49. Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 50. Glenmark Pharmaceuticals Ltd Recent Development
Table 51. Xellia Pharmaceuticals Ltd Company Details
Table 52. Xellia Pharmaceuticals Ltd Business Overview
Table 53. Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 54. Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 55. Xellia Pharmaceuticals Ltd Recent Development
Table 56. Fresenius Medical Care Company Details
Table 57. Fresenius Medical Care Business Overview
Table 58. Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 59. Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 60. Fresenius Medical Care Recent Development
Table 61. Merck & Co., Inc. Company Details
Table 62. Merck & Co., Inc. Business Overview
Table 63. Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 64. Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 65. Merck & Co., Inc. Recent Development
Table 66. Geistlich Pharma AG Company Details
Table 67. Geistlich Pharma AG Business Overview
Table 68. Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 69. Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 70. Geistlich Pharma AG Recent Development
Table 71. TauroPhar GmbH Company Details
Table 72. TauroPhar GmbH Business Overview
Table 73. TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 74. TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 75. TauroPhar GmbH Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Catheter-Related Bloodstream Infections (CRBSIs) Picture
Figure 2. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Type: 2024 VS 2031
Figure 4. Anti-microbial Agents Features
Figure 5. Antibiotic Lock Therapy Features
Figure 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Catheter-Related Bloodstream Infections (CRBSIs) Report Years Considered
Figure 12. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region: 2024 VS 2031
Figure 15. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players in 2024
Figure 16. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2024
Figure 18. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 20. United States Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 24. Germany Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2020-2031)
Figure 32. China Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 40. Mexico Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 44. Turkey Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 48. Xellia Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 49. Fresenius Medical Care Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 51. Geistlich Pharma AG Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 52. TauroPhar GmbH Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-microbial Agents
Table 3. Key Players of Antibiotic Lock Therapy
Table 4. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2020-2025)
Table 8. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2026-2031)
Table 10. Catheter-Related Bloodstream Infections (CRBSIs) Market Trends
Table 11. Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
Table 12. Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
Table 13. Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
Table 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players (2020-2025)
Table 16. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2024)
Table 17. Ranking of Global Top Catheter-Related Bloodstream Infections (CRBSIs) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Headquarters and Area Served
Table 20. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Product and Application
Table 21. Global Key Players of Catheter-Related Bloodstream Infections (CRBSIs), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2020-2025)
Table 25. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2026-2031)
Table 27. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2020-2025)
Table 29. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2026-2031)
Table 31. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Glenmark Pharmaceuticals Ltd Company Details
Table 47. Glenmark Pharmaceuticals Ltd Business Overview
Table 48. Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 49. Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 50. Glenmark Pharmaceuticals Ltd Recent Development
Table 51. Xellia Pharmaceuticals Ltd Company Details
Table 52. Xellia Pharmaceuticals Ltd Business Overview
Table 53. Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 54. Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 55. Xellia Pharmaceuticals Ltd Recent Development
Table 56. Fresenius Medical Care Company Details
Table 57. Fresenius Medical Care Business Overview
Table 58. Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 59. Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 60. Fresenius Medical Care Recent Development
Table 61. Merck & Co., Inc. Company Details
Table 62. Merck & Co., Inc. Business Overview
Table 63. Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 64. Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 65. Merck & Co., Inc. Recent Development
Table 66. Geistlich Pharma AG Company Details
Table 67. Geistlich Pharma AG Business Overview
Table 68. Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 69. Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 70. Geistlich Pharma AG Recent Development
Table 71. TauroPhar GmbH Company Details
Table 72. TauroPhar GmbH Business Overview
Table 73. TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 74. TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025) & (US$ Million)
Table 75. TauroPhar GmbH Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Catheter-Related Bloodstream Infections (CRBSIs) Picture
Figure 2. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Type: 2024 VS 2031
Figure 4. Anti-microbial Agents Features
Figure 5. Antibiotic Lock Therapy Features
Figure 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Catheter-Related Bloodstream Infections (CRBSIs) Report Years Considered
Figure 12. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region: 2024 VS 2031
Figure 15. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players in 2024
Figure 16. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2024
Figure 18. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 20. United States Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 24. Germany Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2020-2031)
Figure 32. China Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 40. Mexico Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2020-2031)
Figure 44. Turkey Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 48. Xellia Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 49. Fresenius Medical Care Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 51. Geistlich Pharma AG Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 52. TauroPhar GmbH Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232